ARGONAUT BIOTECHNOLOGY VENTURES
Live / Applied — Response to non-final action entered (as of 24 Sept 2026)
What this means for you
Not registered yet, but its 01 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99523729
- Mark type
- Word mark
- Filed
- 01 Dec 2025
- Attorney of record
- John K. Burke
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer and other serious diseases, namely, autoimmune, inflammatory and metabolic diseases; Therapeutic pharmaceutical for the treatment of cancer and other serious diseases, namely, autoimmune, inflammatory and metabolic diseases; Pharmaceutical preparations for the treatment of cancer and other serious diseases, namely, autoimmune, inflammatory and metabolic diseases; Pharmaceutical products for the prevention and treatment of cancer; Diagnostic agents for pharmaceutical use; Diagnostic agents for pharmaceutical purposes; Anti-cancer preparations
- Class 042 — Scientific and technological services: Pharmaceutical research services; Pharmaceutical products development; Development of products for others in the field of pharmaceuticals; Pharmaceutical research and development; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of pharmaceuticals; Research and development services in the field of pharmaceutical preparations; Technical research in the field of pharmaceutical studies; Scientific research in the nature of conducting clinical trials for others
Owner
- Argonaut Biotechnology Ventures LLC, Wilmington, DE, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 24 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jul 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 02 Jul 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 06 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Apr 2026 — NON-FINAL ACTION E-MAILED
- 06 Apr 2026 — NON-FINAL ACTION WRITTEN
- 03 Apr 2026 — ASSIGNED TO EXAMINER
- 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 01 Dec 2025 — NEW APPLICATION ENTERED